TRVN - Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket | Benzinga
Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) rose sharply in today's pre-market trading after the company announced expanded US FDA approval of ELEVIDYS to Duchenne Muscular Dystrophy patients ages 4 and above.
Sarepta Therapeutics shares climbed 35.2% to $166.96 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Spectaire Holdings Inc (NASDAQ:SPEC) rose 110% to $0.7140 in pre-market trading after the company announced a purchase order and delivery of its advanced AireCore units to American Ag Energy.
- DermTech, Inc. (NASDAQ:DMTK) gained 105.5% to $0.2423 in pre-market trading after declining 19% on Thursday. DermTech recently filed for Chapter 11 protection and implemented a 20% workforce reduction to preserve cash.
- Trinity Place Holdings Inc. (NYSE:TPHS) shares rose 35.7% to $0.1740 in pre-market trading after gaining more than 5% on Thursday.
- Barinthus Biotherapeutics PLC – ADR (NASDAQ:BRNS) shares rose 25.5% to $1.57 in pre-market trading after dipping 26% on Thursday.
- Zoomcar Holdings, Inc. (NASDAQ:ZCAR) rose 22.5% to $0.1791 in ...